Product Information
CLOMIPRAMINE 75 MG CAPSULE is a generic product labeled by Leading Pharma, LLC, priced at $0.2958 per EA under NDC 69315016501. Its NADAC has been published 274 times since Nov 4, 2020.
FDA first approved this application on Feb 7, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Clomipramine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315016501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
1/21/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211364FDA Approved
2/7/2020
TE Code
AB
On Market Since
3/10/2020
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 75 MG CAPSULE has been published 274 times since Nov 4, 2020, and over the history we have for it it has declined 90.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2958 per EA |
|---|---|
| All-time high | $3.1726 (Nov 11, 2020) |
| All-time low | $0.2871 (May 22, 2024) |
| 52-week high | $0.4054 |
| 52-week low | $0.2958 |
| Median price | $0.5601 |
| Average price | $0.8039 |
| Largest weekly change | +73.5% (Jun 19, 2024) |
| Weeks tracked | 274 |
| Tracking since | Nov 4, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-27.0%
3Y
-47.3%
5Y
-85.9%
All
-90.7%
Last surveyed Jan 28, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 75 MG CAPSULE, manufactured by Leading Pharma, LLC, is $0.2958 per EA (NDC 69315016501), effective Jan 28, 2026.
How has the price of CLOMIPRAMINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 75 MG CAPSULE has declined 90.7%. It has been tracked across 274 weekly CMS publications since Nov 4, 2020.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 75 MG CAPSULE?
Since Nov 4, 2020, the NADAC for CLOMIPRAMINE 75 MG CAPSULE has ranged from a low of $0.2871 (May 22, 2024) to a high of $3.1726 (Nov 11, 2020), with a median of $0.5601 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 75 MG CAPSULE?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLOMIPRAMINE 75 MG CAPSULE, is $0.2636 per EA — about 11% below CLOMIPRAMINE 75 MG CAPSULE.
Who manufactures CLOMIPRAMINE 75 MG CAPSULE?
CLOMIPRAMINE 75 MG CAPSULE (NDC 69315016501) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.